Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Capital Expenditures
Australian Pharmaceutical Industries Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Capital Expenditures
-AU$45.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Paragon Care Ltd
ASX:PGC
|
Capital Expenditures
-AU$16.9m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-29%
|
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Capital Expenditures
-AU$57.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-23%
|
|
Australian Pharmaceutical Industries Ltd
Glance View
Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.
See Also
What is Australian Pharmaceutical Industries Ltd's Capital Expenditures?
Capital Expenditures
-45.9m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Capital Expenditures amounts to -45.9m AUD.
What is Australian Pharmaceutical Industries Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-19%
Over the last year, the Capital Expenditures growth was -15%. The average annual Capital Expenditures growth rates for Australian Pharmaceutical Industries Ltd have been -21% over the past three years , -19% over the past five years .
